Faire d’une pierre deux coups : capture d’hybride

Faire d’une pierre deux coups : capture d’hybride

alt text
Présenté par
Ki Wook Kim
Ki Wook Kim
Maître de conférences et boursier postdoctoral de la FRDJ International, Université de New South Wales
RECORDED AT Writing the Future Asia Pacific

Abordés dans ce webinaire
Exemples d’utilisation du panel respiratoire Twist et comparaison avec d’autres plateformes de capture.
Comment le panel a-t-il été utilisé pour étudier les taux de co-infection chez les patients atteints de SARS-CoV-2 ?
Étiologie virale des maladies chroniques - diabète de type 1 et complications de la grossesse

Accumulating evidence supports the high prevalence of co-infections among Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) patients, and their potential to worsen the clinical outcome of COVID-19. However, there are few data on Southern Hemisphere populations, and most studies to date have investigated a narrow spectrum of viruses using targeted qRT-PCR. We assessed respiratory viral co-infections among SARS-CoV-2 patients in Australia, through respiratory virome characterization. Nasopharyngeal swabs of 92 SARS-CoV-2-positive cases were sequenced using pan-viral hybrid-capture and the Twist Respiratory Virus Panel. In total, 8% of cases were co-infected, with rhinovirus (6%) or influenzavirus (2%). Twist capture also achieved near-complete sequencing (> 90% coverage, > tenfold depth) of the SARS-CoV-2 genome in 95% of specimens with Ct < 30. Our results highlight the importance of assessing all pathogens in symptomatic patients, and the dual-functionality of Twist hybrid-capture, for SARS-CoV-2 whole-genome sequencing without amplicon generation and the simultaneous identification of viral co-infections with ease.

Saisissez vos coordonnées pour regarder le webinaire

 

 

Powered by Translations.com GlobalLink Web Software